Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

278 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Performance of the beta-glucan test for the diagnosis of invasive fusariosis and scedosporiosis: a meta-analysis.
Lamoth F, Nucci M, Fernandez-Cruz A, Azoulay E, Lanternier F, Bremerich J, Einsele H, Johnson E, Lehrnbecher T, Mercier T, Porto L, Verweij PE, White L, Maertens J, Alanio A; 9th European Conference on Infections in Leukemia (ECIL-9). Lamoth F, et al. Med Mycol. 2023 Jul 6;61(7):myad061. doi: 10.1093/mmy/myad061. Med Mycol. 2023. PMID: 37381179 Free PMC article.
Circulatory Inflammatory Proteins as Early Diagnostic Biomarkers for Invasive Aspergillosis in Patients with Hematologic Malignancies-an Exploratory Study.
Aerts R, Ricaño-Ponce I, Bruno M, Mercier T, Rosati D, Maertens J, Kumar V, Carvalho A, Netea MG, Hoenigl M; ECMM Immunologic Markers for Treatment Monitoring and Diagnosis in Invasive Mold Infection Working Group Contributors. Aerts R, et al. Mycopathologia. 2024 Feb 26;189(2):24. doi: 10.1007/s11046-024-00831-8. Mycopathologia. 2024. PMID: 38407673 Free PMC article.
Prevalence and impact of multidrug-resistant bacteria in solid cancer patients with bloodstream infection: a 25-year trend analysis.
Lopera C, Monzó P, Aiello TF, Chumbita M, Peyrony O, Gallardo-Pizarro A, Pitart C, Cuervo G, Morata L, Bodro M, Herrera S, Del Río A, Martínez JA, Soriano A, Puerta-Alcalde P, Garcia-Vidal C. Lopera C, et al. Among authors: garcia vidal c. Microbiol Spectr. 2024 Aug 28:e0296123. doi: 10.1128/spectrum.02961-23. Online ahead of print. Microbiol Spectr. 2024. PMID: 39194256 Free article.
European Study of Cerebral Aspergillosis treated with Isavuconazole: an EFISG study.
Serris A, Rautemaa-Richardson R, Laranjinha J, Candoni A, Garcia-Vidal C, Alastruey-Izquierdo A, Hammarström H, Seidel D, Styczynski J, Sabino R, Lamoth F, Prattes J, Warris A, Porcher R, Lanternier F; ESCAI study group and EFISG. Serris A, et al. Among authors: garcia vidal c. Clin Infect Dis. 2024 Jul 30:ciae371. doi: 10.1093/cid/ciae371. Online ahead of print. Clin Infect Dis. 2024. PMID: 39076104
Chimeric Antigen Receptor T-Cell Postinfusion Fever: Infection Profile, Clinical Parameters, and Biomarkers Trends to Assist Antibiotic Stewardship.
Peyrony O, Garcia-Pouton N, Chumbita M, Teijon-Lumbreras C, Aiello TF, Monzó-Gallo P, Gallardo-Pizarro A, Ortiz-Maldonado V, Martinez-Cibrian N, Delgado J, Fernandez de Larrea C, Mensa J, Puerta-Alcalde P, Soriano A, Garcia-Vidal C. Peyrony O, et al. Among authors: garcia vidal c. Open Forum Infect Dis. 2024 Jul 11;11(7):ofae398. doi: 10.1093/ofid/ofae398. eCollection 2024 Jul. Open Forum Infect Dis. 2024. PMID: 39070045 Free PMC article.
Corrigendum to "Safety and effectiveness of isavuconazole in real-life non-neu tropenic patients" [International Journal of Infectious Diseases 144 (2024) 107070].
Monzó-Gallo P, Lopera C, Badía-Tejero AM, Machado M, García-Rodríguez J, Vidal-Cortés P, Merino E, Calderón J, Fortún J, Palacios-Baena ZR, Pemán J, Sanchis JR, Aguilar-Guisado M, Gudiol C, Ramos JC, Sánchez-Romero I, Martin-Davila P, López-Cortés LE, Salavert M, Ruiz-Camps I, Chumbita M, Aiello TF, Peyrony O, Puerta-Alcalde P, Soriano A, Marco F, Garcia-Vidal C. Monzó-Gallo P, et al. Among authors: garcia vidal c. Int J Infect Dis. 2024 Sep;146:107188. doi: 10.1016/j.ijid.2024.107188. Epub 2024 Jul 26. Int J Infect Dis. 2024. PMID: 39067149 Free article. No abstract available.
Attributable mortality of candidemia - Results from the ECMM Candida III multinational European Observational Cohort Study.
Salmanton-García J, Cornely OA, Stemler J, Barać A, Steinmann J, Siváková A, Akalin EH, Arikan-Akdagli S, Loughlin L, Toscano C, Narayanan M, Rogers B, Willinger B, Akyol D, Roilides E, Lagrou K, Mikulska M, Denis B, Ponscarme D, Scharmann U, Azap A, Lockhart D, Bicanic T, Kron F, Erben N, Rautemaa-Richardson R, Goodman AL, Garcia-Vidal C, Lass-Flörl C, Gangneux JP, Taramasso L, Ruiz M, Schick Y, Van Wijngaerden E, Milacek C, Giacobbe DR, Logan C, Rooney E, Gori A, Akova M, Bassetti M, Hoenigl M, Koehler P. Salmanton-García J, et al. Among authors: garcia vidal c. J Infect. 2024 Sep;89(3):106229. doi: 10.1016/j.jinf.2024.106229. Epub 2024 Jul 16. J Infect. 2024. PMID: 39025408 Free article.
Extended remdesivir administration in haematological patients with malignancies and COVID-19 during the Omicron era: safety and outcomes.
Gras E, Aiello TF, Chumbita M, Gallardo-Pizarro A, Monzó-Gallo P, Teijón-Lumbreras C, Suárez-Lledó M, Magnano L, Tuset M, Marcos MÁ, Soriano A, Garcia-Vidal C. Gras E, et al. Among authors: garcia vidal c. J Antimicrob Chemother. 2024 Sep 3;79(9):2364-2368. doi: 10.1093/jac/dkae237. J Antimicrob Chemother. 2024. PMID: 38985649
Corrigendum: C-reactive protein isoforms as prognostic markers of COVID-19 severity.
Molins B, Figueras-Roca M, Valero O, Llorens V, Romero-Vázquez S, Sibila O, Adan A, Garcia-Vidal C, Soriano A. Molins B, et al. Among authors: garcia vidal c. Front Immunol. 2024 Jun 21;15:1447976. doi: 10.3389/fimmu.2024.1447976. eCollection 2024. Front Immunol. 2024. PMID: 38975342 Free PMC article.
278 results